NPPB and cardiac arrhythmia: In this study, cardiotoxicity was defined by a reduction in LVEF by ≥10% and LVEF < 53% or HF defined as LVEF < 40% or BNP > 35 ng/L plus NT-proBNP >1 25 ng/L or acute coronary artery syndrome or severe arrhythmia.